Avecia Biologics has launched a toolkit of technologies for producing antibody fragment therapeutics. The toolkit combines Avecia's high yield microbial expression system with downstream technologies for purification, refold and PEGylation.
Avecia
Thursday 14 May 2009
Avecia launches antibody fragment toolkit
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment